Statistics about Health, Pharma & Medtech in United States
Statistics
- Support/oppose increased funding for research on opioid addiction U.S. 2024
- U.S. adults not taking medicine as prescribed 2021, by insurance status
- U.S. adults not taking medicine as prescribed by disability and health status 2021
- Share of U.S. adults not taking medicine as prescribed to reduce costs 2021, by race
- Share of U.S. adults not taking medicine as prescribed to reduce costs 2021, by age
- Share of U.S. adults not taking medicine as prescribed to reduce costs 2021 by gender
- Outpatient oral antibiotic prescriptions in the United States 2011-2022
- Federal drug control spending share in the U.S. in FY 2025 by function
- Total revenue of Perjeta 2018-2022, by region
- Number of approved ANDAs in U.S. 2009-2023
- Cost of Medicare PDP premiums in 2023, by US state
- Annual brand name Rx drug price change for drugs among older Americans 2006-2020
- Price increase select geriatric drugs in the U.S. in 2020
- Annual retail price for widely used branded Rx rugs among older Americans 2006-2020
- Number of prescription drug armed robberies in U.S. 2010-2019
- Potency of methamphetamine in the U.S. by half-year 2012-2019
- Methamphetamine laboratory incidents in the U.S. 2000-2019
- Fentanyl combination exhibits in U.S. 2015-2019
- Total U.S. population with 5 or more prescriptions within 30 days 1988-2018
- U.S. population with 5 or more prescriptions within 30 days by age 1988-2018
- U.S. population with 5 or more prescriptions within 30 days by gender 1988-2018
- U.S. population with 3 or more prescriptions within 30 days by gender 1988-2018
- Total U.S. population with 3 or more prescriptions within 30 days 1988-2018
- U.S. population with usage of Rx drugs within 30 days by gender 1988-2018
- Total U.S. population with usage of prescription drugs within 30 days 1988-2018
- Drug overdose male death rates in the U.S. 2018, by age
- U.S. glaucoma prescription market distribution by product type 2019
- Industry revenue of “pharmaceutical and medicine manufacturing“ in the U.S. 2012-2024
- Drug products in the pipeline in California 2020, by therapeutic area
- Active immuno-oncological agents in development U.S. 2019, by type
- Phase 3 Alzheimer's drugs in development July 2019, by mechanism of action
- Phase 2 Alzheimer's drugs in development July 2019, by mechanism of action
- U.S. public opinion on antibiotic overuse 2019
- Generics prescriptions dispensed in the U.S. 2010-2019
- Anxiety among U.S. cancer patients loved ones regarding financial situation 2019
- Leading U.S. pharmaceutical products by revenue 2026
- Top U.S. states based on number of retail prescriptions per capita 2019
- Anxiety among U.S. cancer patients regarding their financial situation 2019
- Views on medical cannabis use among U.S. adults 2019, by generation
- Views on medical cannabis use in the U.S. among adults by gender 2019
- FDA on breakthrough therapy requests by status 2019
- U.S. prescription drug prices opinions in 2019 by attitude toward Trump
- U.S. prescription drug prices opinions in 2019 by political orientation
- U.S. prescription drug prices opinions 2019
- Total sales of oral solid opioids in the U.S. 2010-2017
- Morphine equivalents: oral solid opioids share in U.S. by drug 2010-2017
- Rx oral solid opioids market share for morphine equivalents U.S. 2017, by drug
- U.S. dollar share of the leading parasite treatment brands 2019
- Sales change of the leading parasite treatment brands in the U.S. 2019
- Average price of the leading parasite treatment brands in the U.S. 2019
- Unit sales of the leading parasite treatment brands in the U.S. 2019
- Rx drugs by type used widely by older Americans 2017
- U.S. top OTC brands for sleep remedies by sales 2018-2019
- Leading parasite treatment brands in the U.S. 2019, based on sales
- Number of cumulative orphan designations accepted in the U.S. 2003-2018
- U.S. addiction medication clinical trials in 2018, by phase and indication
- Novel pain drug clinical trials success rates U.S. 2006-2015, by phase
- Obesity clinical trial success rates for novel drugs U.S. 2006-2015 by phase
- Clinical trial starts for new obesity drugs U.S. 2008-2017
- Obesity drugs clinical pipeline U.S. 2018, by type and phase
- Type 2 diabetes clinical trial success rates U.S. 2006-2015, by phase and indication
- Clinical trials starts for new type 2 diabetes drugs U.S. 2008-2017
- Time from orphan drug design to final exclusivity 2018, by current status
- U.S. orphan drugs with patents and orphan drug exclusivity as of 2018, by duration
- U.S. orphan drugs with patents and orphan drug exclusivity as of 2018
- U.S. veterans of Iraq and Afghanistan who had used medical cannabis as of 2018
- Market share of orphan drugs valued >$6,000 per year 2017, by therapy class
- Specialty drug spending growth characteristics in the U.S. 2012-2017
- Drug spending in the U.S. 2013-2017, by specialty and orphan status
- Percentage of select orphan drug US sales by non/orphan use 2017
- FDA approved orphan drugs 1983-2018, by approval sequence
- FDA approved orphan drugs with non-orphan indications 1983-2018
- US human growth hormone market share by application 2014-2025
- Production licenses per medical cannabis retailer in the U.S. 2018, by state
- Medical cannabis production licenses in the U.S. 2018, by state
- Population per U.S. medical cannabis retailer 2018, by select state
- Number of U.S. medical cannabis retail licenses 2018, by state
- Penetration rate of U.S. medical cannabis by select state 2018
- Wholesale price of U.S. medical cannabis 2018, by state
- Drug price changes in the U.S. by product group until end-2019
- Percentage of Medicaid patients receiving new hypertension drugs by location 2017
- Leading U.S. states by synthetic pain medication overdose death rate 2016
- Top U.S. states by fentanyl overdose death rate in 2016
- Number of Wisconsin controlled prescriptions lost in transit incidents 2014-2017
- Number of fentanyl-related substances identified in U.S. 2017, by type
- Botanical IND applications to the FDA 2002-2016
- Botanical INDs at the FDA by therapy area 2017
- Total U.S. OTC hyaluronic acid market size by application 2014-2024
- Total U.S. OTC hyaluronic acid market size 2014-2024
- Total U.S. hyaluronic acid raw material market size 2014-2024
- U.S. hyaluronic acid raw material market size 2014-2024, by application
- Reasons for missing a dose of prescribed medication in the U.S. 2017, by generation
- Reasons for missing a dose of prescribed medication in the U.S. 2017, by age
- Usage of prescribed sex hormone drugs among U.S. women 1988-2014
- Prescribed sex hormone drugs: usage among U.S. women by age 1988-2014
- Leading hair growth products in U.S. 2018
- Top selling hair growth product brands in U.S. 2018
- Market share of hair growth products in U.S. 2018
- Drugs in development with potential to be first-in-class in 2016, by therapeutic area
- U.S. average invoice price increase for oncology brands 2012-2017